申请人:MannKind Corporation
公开号:US20140080833A1
公开(公告)日:2014-03-20
Intracellular kinase inhibitors and their therapeutic uses for patients with T cell malignancies, B cell malignancies, autoimmune disorders, and transplanted organs.
细胞内激酶抑制剂及其治疗用于T细胞恶性肿瘤、B细胞恶性肿瘤、自身免疫性疾病和移植器官的患者。